Magnetization transfer imaging in premanifest and manifest Huntington disease
- PMID: 22241387
- PMCID: PMC7968816
- DOI: 10.3174/ajnr.A2868
Magnetization transfer imaging in premanifest and manifest Huntington disease
Abstract
Background and purpose: MTI has the potential to detect abnormalities in normal-appearing white and gray matter on conventional MR imaging. Early detection methods and disease progression markers are needed in HD research. Therefore, we investigated MTI parameters and their clinical correlates in premanifest and manifest HD.
Materials and methods: From the Leiden TRACK-HD study, 78 participants (28 controls, 25 PMGC, 25 MHD) were included. Brain segmentation of cortical gray matter, white matter, caudate nucleus, putamen, pallidum, thalamus, amygdala, and hippocampus was performed using FSL's automated tools FAST and FIRST. Individual MTR values were calculated from these regions and MTR histograms constructed. Regression analysis of MTR measures from all gene carriers with clinical measures was performed.
Results: MTR peak height was reduced in both cortical gray (P = .01) and white matter (P = .006) in manifest HD compared with controls. Mean MTR was also reduced in cortical gray matter (P = .01) and showed a trend in white matter (P = .052). Deep gray matter structures showed a uniform pattern of reduced MTR values (P < .05). No differences between premanifest gene carriers and controls were found. MTR values correlated with disease burden and motor and cognitive impairment.
Conclusions: Throughout the brain, disturbances in MTI parameters are apparent in early HD and are homogeneous across white and gray matter. The correlation of MTI with clinical measures indicates the potential to act as a disease monitor in clinical trials. However, our study does not provide evidence for MTI as a marker in premanifest HD.
Figures


Similar articles
-
Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up.AJNR Am J Neuroradiol. 2013 Feb;34(2):317-22. doi: 10.3174/ajnr.A3303. Epub 2012 Aug 23. AJNR Am J Neuroradiol. 2013. PMID: 22918430 Free PMC article. Clinical Trial.
-
Magnetization transfer imaging in 'premanifest' Huntington's disease.J Neurol. 2010 Mar;257(3):426-32. doi: 10.1007/s00415-009-5339-4. Epub 2009 Oct 13. J Neurol. 2010. PMID: 19823894 Free PMC article.
-
Linking white matter and deep gray matter alterations in premanifest Huntington disease.Neuroimage Clin. 2016 Feb 26;11:450-460. doi: 10.1016/j.nicl.2016.02.014. eCollection 2016. Neuroimage Clin. 2016. PMID: 27104139 Free PMC article.
-
Structural Magnetic Resonance Imaging in Huntington's Disease.Int Rev Neurobiol. 2018;142:335-380. doi: 10.1016/bs.irn.2018.09.006. Epub 2018 Oct 8. Int Rev Neurobiol. 2018. PMID: 30409258 Review.
-
Magnetization transfer imaging for in vivo detection of microstructural tissue changes in aging and dementia: a short literature review.J Alzheimers Dis. 2014;42 Suppl 3:S229-37. doi: 10.3233/JAD-132750. J Alzheimers Dis. 2014. PMID: 24840568 Review.
Cited by
-
Huntington disease: natural history, biomarkers and prospects for therapeutics.Nat Rev Neurol. 2014 Apr;10(4):204-16. doi: 10.1038/nrneurol.2014.24. Epub 2014 Mar 11. Nat Rev Neurol. 2014. PMID: 24614516 Review.
-
Lower Blood Pressure and Gray Matter Integrity Loss in Older Persons.J Clin Hypertens (Greenwich). 2015 Aug;17(8):630-7. doi: 10.1111/jch.12550. Epub 2015 Apr 13. J Clin Hypertens (Greenwich). 2015. PMID: 25867921 Free PMC article.
-
Association between changes in brain microstructure and cognition in older subjects at increased risk for vascular disease.BMC Neurol. 2015 Aug 7;15:133. doi: 10.1186/s12883-015-0396-z. BMC Neurol. 2015. PMID: 26249665 Free PMC article.
-
Quantitative multi-modal MRI of the Hippocampus and cognitive ability in community-dwelling older subjects.Cortex. 2014 Apr;53(100):34-44. doi: 10.1016/j.cortex.2013.12.012. Epub 2013 Dec 31. Cortex. 2014. PMID: 24561387 Free PMC article.
-
Parameters of glucose metabolism and the aging brain: a magnetization transfer imaging study of brain macro- and micro-structure in older adults without diabetes.Age (Dordr). 2015 Aug;37(4):9802. doi: 10.1007/s11357-015-9802-0. Epub 2015 Jul 17. Age (Dordr). 2015. PMID: 26178969 Free PMC article.
References
-
- Novak MJ, Tabrizi SJ. Huntington's disease. BMJ 2010;340:c3109. - PubMed
-
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72:971–83 - PubMed
-
- de la Monte SM, Vonsattel JP, Richardson EP, Jr.. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988;47:516–25 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical